Sort by
Refine Your Search
-
, and scholarly activities. In partnership with Northeastern University, Intellia Therapeutics is offering a two-year Global Medical Affairs fellowship, based in Cambridge, MA. About Intellia Intellia
-
Affairs fellowship, based in Cambridge, MA. About Alnylam Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with
-
, and scholarly activities. In partnership with Northeastern University, Dompe is offering a two-year Global Regulatory Affairs fellowship, based Remote with the option to relocate to San Mateo, CA
-
Regulatory Affairs fellowship, based in Cambridge, MA. About Alnylam Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines
-
, and scholarly activities. In partnership with Northeastern University, Alnylam Pharmaceuticals is offering a two-year Regulatory Affairs fellowship, based in Cambridge, MA. About Alnylam Alnylam
-
, and scholarly activities. In partnership with Northeastern University, Takeda Pharmaceutical Company is offering a two-year Global Medical Affairs fellowship, based in Cambridge, MA (Boston area). About
-
, and scholarly activities. In partnership with Northeastern University, Alnylam Pharmaceuticals is offering a two-year Global Medical Affairs TTR fellowship, based in Cambridge, MA. About Alnylam Alnylam
-
Global Medical Information fellowship, based in Cambridge, MA. About Alnylam Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative
-
, a7nAChR, a9* nAChR, GIRK1/2, GIRK1/4etc.). Key initial responsibilities will include biochemical and ADME/PK studies and data analysis, SAR hypothesis generation, empirical and structure-based target design
-
Affairs fellowship, based in Cambridge, MA. About Alnylam Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with